Matching articles for "Dymista"
Issue 1725 · March 31, 2025 Free
Treatment of Allergic Rhinitis and Allergic Conjunctivitis

Initial treatment of allergic rhinitis (AR) depends on the severity of symptoms and whether they are intermittent or persistent (see Table 1).

Med Lett Drugs Ther. 2025 Mar 31; 67(1725):49-56 doi:10.58347/tml.2025.1725a
Initial treatment of allergic rhinitis (AR) depends on the severity of symptoms and whether they are intermittent or persistent (see Table 1).
Issue 1725 · March 31, 2025
Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis (online only)

View the Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis

Med Lett Drugs Ther. 2025 Mar 31; 67(1725):e58-63 doi:10.58347/tml.2025.1725c
View the Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis
Issue 1668 · January 23, 2023
Olopatadine/Mometasone (Ryaltris) for Allergic Rhinitis

The FDA has approved Ryaltris (Hikma), a fixed-dose combination nasal spray containing the H 1 -antihistamine olopatadine hydrochloride ( Patanase , and generics) and the corticosteroid mometasone furoate (…

Med Lett Drugs Ther. 2023 Jan 23; 65(1668):12-4 doi:10.58347/tml.2023.1668c
The FDA has approved Ryaltris (Hikma), a fixed-dose combination nasal spray containing the H 1 -antihistamine olopatadine hydrochloride ( Patanase , and generics) and the corticosteroid mometasone furoate ( Nasonex 24 HR Allergy , and generics), for treatment of seasonal allergic rhinitis symptoms in persons ≥12 years old. Ryaltris is the second intranasal antihistamine/corticosteroid combination to be approved for this indication; azelastine 0.1%/fluticasone propionate ( Dymista , and generics), which is approved for use in persons ≥6 years old, was the first. Both products are available only by prescription.
Issue 1622 · April 19, 2021
Drugs for Allergic Rhinitis and Allergic Conjunctivitis

The choice of drugs for treatment of allergic rhinitis depends on the severity of symptoms and whether they are intermittent or persistent (see Table 1).

Med Lett Drugs Ther. 2021 Apr 19; 63(1622):57-64
The choice of drugs for treatment of allergic rhinitis depends on the severity of symptoms and whether they are intermittent or persistent (see Table 1).
Issue 1622 · April 19, 2021
Comparison Table: Some Oral Drugs for Allergic Rhinitis (online only)

View the Comparison Table: Some Oral Drugs for Allergic Rhinitis

Med Lett Drugs Ther. 2021 Apr 19; 63(1622):e63-5
View the Comparison Table: Some Oral Drugs for Allergic Rhinitis
Issue 1622 · April 19, 2021
Comparison Table: Some Nasal Sprays for Allergic Rhinitis (online only)

View the Comparison Table: Some Nasal Sprays for Allergic Rhinitis

Med Lett Drugs Ther. 2021 Apr 19; 63(1622):e66-71
View the Comparison Table: Some Nasal Sprays for Allergic Rhinitis
Issue 1520 · May 8, 2017
Drugs for Allergic Disorders

Allergic rhinitis can be classified as seasonal, perennial, or episodic. It is often associated with allergic conjunctivitis, rhinosinusitis, and asthma. H 1 -ANTIHISTAMINES — Oral – Oral second-generation…

Med Lett Drugs Ther. 2017 May 8; 59(1520):71-82
Allergic rhinitis can be classified as seasonal, perennial, or episodic. It is often associated with allergic conjunctivitis, rhinosinusitis, and asthma. H 1 -ANTIHISTAMINES — Oral – Oral second-generation H 1 -antihistamines are the preferred first-line treatment for relief of the itching, sneezing, and rhinorrhea that characterize mild-to-moderate allergic rhinitis. They are less effective for nasal congestion.
Issue 1520 · May 8, 2017
Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis (online only)

View the Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis

Med Lett Drugs Ther. 2017 May 8; 59(1520):e85-90
View the Comparison Table: Some Nasal Sprays for Seasonal Allergic Rhinitis
Issue 129 · May 1, 2013
Drugs for Allergic Disorders

The use of drugs to prevent and control symptoms of allergic disorders can be optimized when patients avoid exposure to specific allergens and/or environmental conditions that trigger or worsen their symptoms.

Treat Guidel Med Lett. 2013 May; 11(129):43-52
The use of drugs to prevent and control symptoms of allergic disorders can be optimized when patients avoid exposure to specific allergens and/or environmental conditions that trigger or worsen their symptoms.
Issue 1402 · October 29, 2012
Azelastine/Fluticasone Propionate (Dymista) for Seasonal Allergic Rhinitis

The FDA has approved a nasal spray fixed-dose combination ( Dymista – Meda) of the H 1 -antihistamine azelastine ( Astelin, Astepro, and generics) and the corticosteroid fluticasone propionate ( Flonase, and…

Med Lett Drugs Ther. 2012 Oct 29; 54(1402):85-7
The FDA has approved a nasal spray fixed-dose combination ( Dymista – Meda) of the H 1 -antihistamine azelastine ( Astelin, Astepro, and generics) and the corticosteroid fluticasone propionate ( Flonase, and generics) for treatment of seasonal allergic rhinitis (SAR) in patients ≥12 years old who need both medications for symptomatic relief. It is the first nasal spray to be approved in the US that contains both an H 1 -antihistamine and a corticosteroid.